Navigation Links
CMEFirst Presents State-of-the-Art Arthritis CME Symposium
Date:3/18/2009

MORRISTOWN, N.J., March 18 /PRNewswire/ -- Concerns still persist within the general clinical community regarding the cardiovascular and gastrointestinal risk that is associated with the use of analgesics such as the nonsteroidal anti-inflammatory drugs (NSAIDs). In particular, the use of COX-2 selective inhibitor NSAIDs continues to raise the concern of cardio-renal complications not only in the decision making process of physicians but also in the perception of many patients who still recall the media blitz of reports surrounding the cardiovascular complications associated with the long term use of Vioxx and other "COX-2" analgesics. This is remarkable since simple analgesics such as acetaminophen (Tylenol(R)) and the NSAIDs are the single most commonly used and prescribed category of drug on a world wide basis. Hence, to address these important clinical day-to-day patient management concerns, CMEFirst, LLC, developed and convened a CME symposium on February 7, 2009, at the Omni Hotel in central Los Angeles.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090318/NY85776 )

The location was chosen to ensure the availability of a large number of primary care physicians, internists, orthopedic surgeons, and pain specialists. The faculty recruited for the symposium represented a national and international group of renowned clinicians and investigators who have had extensive experience in the clinical development of analgesics and NSAID compounds from the perspective of clinical trial investigation as well as FDA advisory roles in the decision making processes that lead to the approval and regulation of the use of these drugs.

The initial speaker at the symposium, Allan Gibofsky, MD, JD, is an acclaimed Rheumatologist and is past Chairman of the FDA Arthritis Advisory Committee. In addition, Dr. Gibofsky is the former President of The
'/>"/>

SOURCE CMEFirst
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Wayne County Community College District Presents Second Annual Child Car Seat Check Program
2. NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma
3. IPC The Hospitalist Company Presents IPC Hospitalist of the Year Award to Tim Osonma, M.D.
4. National Center for Creative Aging Presents Creativity Matters Symposium on Health, Wellness, and the Arts
5. ACRO Presents at Japan CRO Association Commemorative Symposium
6. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
7. Los Angeles Jewish Home Support Group Presents Humanitarian Award and Visionary Award
8. Penn Medicine presents HIV gene therapy trial data at CROI 2009
9. Mexico Presents Flawed Theory in Shooting Death of American Journalist
10. Illinois Department of Veterans Affairs Presents $97,500 Veterans Cash Grant to Alexian Brothers Hospital Network
11. Womans Day Presents the Sixth Annual Red Dress Awards Honoring Women Making Strides in the Fight Against Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Biostimulants are widely applied in turf ... ornamentals. These also help turf and ornamentals in absorption ... Turf, ornamentals, and flowers appear healthy and strong as ... increased from the last few years. The most dominating ... Europe, with around 40% share in 2013, and is ...
(Date:7/11/2014)... and overweight firefighters are not receiving weight management ... new research from The University of Texas Health ... state that health care professionals (HCPs) should advise ... weight. Firefighters have high rates of obesity, and ... deaths in firefighters. This study assessed the association ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, ... from the worldwide scourge of dengue fever was somewhat successful ... only prevented dengue fever in 56 percent of the 10,000 ... protected more than 88 percent of them from severe disease. ... and sometimes death. "This vaccine has already proven to ...
(Date:7/11/2014)... VA (PRWEB) July 11, 2014 Riverside Health ... Care (CBCC) in Virginia in late 2012 and now, ... ChooseHome – to residents throughout the Williamsburg and Newport News ... programs provide services and benefits to independent older adults who ... access to a safety net of continuing care services as ...
(Date:7/11/2014)... 11, 2014 Pigments are insoluble colorants, ... three functions namely protective coating, opacity, and coloring. These ... that impart color to substances such as paper, paints, ... pigments, which upon application impart color to the substance. ... carbon black, and hematite. , The coloring action of ...
Breaking Medicine News(10 mins):Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3
... Acquisition Will Extend Product Offering to Healthcare Customers, ... CLAI), a leading provider of electronic transaction services ... entered into an agreement,to acquire substantially all the ... The agreement is subject to due diligence and ...
... DES MOINES, Iowa, Dec. 13 If Congress passes,legislation ... authority,to regulate tobacco products, the new law would save ... keeping 25,700 kids from,becoming new smokers, according to a ... Senator Tom Harkin is a cosponsor of the,legislation. Senator ...
... part of St. Josephs Health Care, London and a ... at The University of Western Ontario. His team ... thousand Canadian peacekeeping veterans with service-related disabilities. The ... served with the Canadian Forces from 1990 to 1999. ...
... publishers, will begin publishing La Chirurgia degli Organi de ... is the official publication of the Istituti Ortopedici Rizzoli, ... It is published three times a year entirely ... Musculoskeletal Surgery, founded in 1917 at the Istituti ...
... COLUMBIA, Mo. Researchers from the University of Missouri ... vaccines directed against the virus that causes AIDS and ... published in the Dec. 14 edition of The Journal ... than a decade, Gary Clark, associate professor of Obstetrics, ...
... 13, 2007 Schizophrenia is one of the most debilitating ... the most difficult to treat. Although numerous antipsychotic treatments ... patients experience only a partial relief of their symptoms and ... new study scheduled for publication in the December 15th issue ...
Cached Medicine News:Health News:Claimsnet to Acquire Acceptius 2Health News:New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking 2Health News:New Report: Tobacco Regulation Would Save Iowa $449 Million in Health Care Costs by Preventing 25,700 Kids from Smoking 3Health News:New study suggests why vaccines directed against cancer, HIV don't work 2Health News:Effective new treatment for schizophrenia 2
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
Breaking Medicine Technology:Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... A. Grant, MD,Retina Macular Care, presented the ... that was designed to evaluate the adjuvant,use ... Lucentis(R),(ranibizumab) treatment of choroidal neovascularization secondary to,age-related ... presentation at,the 2008 Annual Meeting of the ...
... C Therapies Provides ... Clinical Practice, MILAN, Italy, April 26 Final ... study comparing the,leading therapies for chronic hepatitis C, were ... Association for the Study of the Liver,(EASL), providing important ...
Cached Medicine Technology:Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10